Cargando…

Rapid and Long-Term Immunity Elicited by DNA-Encoded Antibody Prophylaxis and DNA Vaccination Against Chikungunya Virus

Background. Vaccination and passive antibody therapies are critical for controlling infectious diseases. Passive antibody administration has limitations, including the necessity for purification and multiple injections for efficacy. Vaccination is associated with a lag phase before generation of imm...

Descripción completa

Detalles Bibliográficos
Autores principales:	Muthumani, Karuppiah, Block, Peter, Flingai, Seleeke, Muruganantham, Nagarajan, Chaaithanya, Itta Krishna, Tingey, Colleen, Wise, Megan, Reuschel, Emma L., Chung, Christopher, Muthumani, Abirami, Sarangan, Gopalsamy, Srikanth, Padma, Khan, Amir S., Vijayachari, Paluru, Sardesai, Niranjan Y., Kim, J. Joseph, Ugen, Kenneth E., Weiner, David B.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2016
Materias:	Major Articles and Brief Reports
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4936642/ https://www.ncbi.nlm.nih.gov/pubmed/27001960 http://dx.doi.org/10.1093/infdis/jiw111

Ejemplares similares

A DNA Vaccine against Chikungunya Virus Is Protective in Mice and Induces Neutralizing Antibodies in Mice and Nonhuman Primates
por: Mallilankaraman, Karthik, et al.
Publicado: (2011)

Co-Administration of Molecular Adjuvants Expressing NF-Kappa B Subunit p65/RelA or Type-1 Transactivator T-bet Enhance Antigen Specific DNA Vaccine-Induced Immunity
por: Shedlock, Devon J., et al.
Publicado: (2014)

Chikungunya: A Potentially Emerging Epidemic?
por: Thiboutot, Michelle M., et al.
Publicado: (2010)

Chronic inflammatory arthritis with persisting bony erosions in patients following chikungunya infection
por: Chaaithanya, Itta Krishna, et al.
Publicado: (2014)

HIV-1 Env DNA Vaccine plus Protein Boost Delivered by EP Expands B- and T-Cell Responses and Neutralizing Phenotype In Vivo
por: Muthumani, Kar, et al.
Publicado: (2013)

Synthetic DNA Vaccines: Improved Vaccine Potency by Electroporation and Co-Delivered Genetic Adjuvants
por: Flingai, Seleeke, et al.
Publicado: (2013)

Genetic characterization of Chikungunya virus 2009 isolates from South India
por: Sarangan, Gopalsamy, et al.
Publicado: (2018)

Protection against dengue disease by synthetic nucleic acid antibody prophylaxis/immunotherapy
por: Flingai, Seleeke, et al.
Publicado: (2015)

A synthetic consensus anti-Spike protein DNA vaccine induces protective immunity against Middle East Respiratory Syndrome Coronavirus in non-human primates
por: Muthumani, K., et al.
Publicado: (2016)

436. Developing a Synthetic DNA Vaccine for an Emerging Pathogen - Middle East Respiratory Syndrome
por: Reuschel, Emma L., et al.
Publicado: (2016)

Novel prostate cancer immunotherapy with a DNA-encoded anti-prostate-specific membrane antigen monoclonal antibody
por: Muthumani, Kar, et al.
Publicado: (2017)

An engineered bispecific DNA-encoded IgG antibody protects against Pseudomonas aeruginosa in a pneumonia challenge model
por: Patel, Ami, et al.
Publicado: (2017)

Novel strategy for generation of mucosal immune responses against HIV-1 following systemic vaccination
por: Kutzler, Michele A, et al.
Publicado: (2006)

A novel synthetic DNA vaccine elicits protective immune responses against Powassan virus
por: Choi, Hyeree, et al.
Publicado: (2020)

REDD1 Is Essential for Optimal T Cell Proliferation and Survival
por: Reuschel, Emma L., et al.
Publicado: (2015)

DMAb inoculation of synthetic cross reactive antibodies protects against lethal influenza A and B infections
por: Elliott, Sarah T. C., et al.
Publicado: (2017)

Chikungunya Fever, Andaman and Nicobar Islands, India
por: Manimunda, Sathya P., et al.
Publicado: (2007)

Designed DNA-Encoded IL-36 Gamma Acts as a Potent Molecular Adjuvant Enhancing Zika Synthetic DNA Vaccine-Induced Immunity and Protection in a Lethal Challenge Model
por: Louis, Lumena, et al.
Publicado: (2019)

Characterization of guinea pig T cell responses elicited after EP-assisted delivery of DNA vaccines to the skin
por: Schultheis, Katherine, et al.
Publicado: (2016)

Neutralization of hepatitis B virus by a novel DNA-encoded monoclonal antibody
por: Zankharia, Urvi S., et al.
Publicado: (2020)

Association of dengue virus infection susceptibility with polymorphisms of 2′-5′-oligoadenylate synthetase genes: a case–control study
por: Thamizhmani, Ramanathan, et al.
Publicado: (2014)

In vivo protection against ZIKV infection and pathogenesis through passive antibody transfer and active immunisation with a prMEnv DNA vaccine
por: Muthumani, Karuppiah, et al.
Publicado: (2016)

Minimally invasive and surface electroporation delivery of DNA vaccines for the induction of robust humoral immune responses against HIV antigens
por: Sardesai, NY, et al.
Publicado: (2012)

Simplifying checkpoint inhibitor delivery through in vivo generation of synthetic DNA-encoded monoclonal antibodies (DMAbs)
por: Perales-Puchalt, Alfredo, et al.
Publicado: (2019)

Robust antibody and cellular responses with an improved DNA vaccine alone
por: Hutnick, N, et al.
Publicado: (2012)

Molecular xenomonitoring of diurnally subperiodic Wuchereria bancrofti infection in Aedes (Downsiomyia) niveus (Ludlow, 1903) after nine rounds of Mass Drug Administration in Nancowry Islands, Andaman and Nicobar Islands, India
por: Premkumar, Addepalli, et al.
Publicado: (2020)

Protective immunity by an engineered DNA vaccine for Mayaro virus
por: Choi, Hyeree, et al.
Publicado: (2019)

Synthetic DNA delivery by electroporation promotes robust in vivo sulfation of broadly neutralizing anti-HIV immunoadhesin eCD4-Ig
por: Xu, Ziyang, et al.
Publicado: (2018)

Tsunami, post-tsunami malaria situation in Nancowry group of islands, Nicobar district, Andaman and Nicobar Islands
por: Manimunda, Sathya Prakash, et al.
Publicado: (2011)

ZIKA-001: Safety and Immunogenicity of an Engineered DNA Vaccine Against ZIKA virus infection
por: Tebas, Pablo, et al.
Publicado: (2017)

Rapid response to an emerging infectious disease – Lessons learned from development of a synthetic DNA vaccine targeting Zika virus
por: Kudchodkar, Sagar B., et al.
Publicado: (2018)

Pregnancy outcomes among Indian women: increased prevalence of miscarriage and stillbirth during 2015–2021
por: Kuppusamy, Periyasamy, et al.
Publicado: (2023)

Highlights of the DNA Vaccines 2011 Meeting
por: Ugen, Kenneth E., et al.
Publicado: (2012)

DNA Vaccines for Epidemic Preparedness: SARS-CoV-2 and Beyond
por: Maslow, Joel N., et al.
Publicado: (2023)

Harnessing Recent Advances in Synthetic DNA and Electroporation Technologies for Rapid Vaccine Development Against COVID-19 and Other Emerging Infectious Diseases
por: Xu, Ziyang, et al.
Publicado: (2020)

A novel regulation of VEGF expression by HIF-1α and STAT3 in HDM2 transfected prostate cancer cells
por: Rathinavelu, Appu, et al.
Publicado: (2012)

Development of Novel DNA-Encoded PCSK9 Monoclonal Antibodies as Lipid-Lowering Therapeutics
por: Khoshnejad, Makan, et al.
Publicado: (2019)

Active Immunoprophylaxis and Vaccine Augmentations Mediated by a Novel Plasmid DNA Formulation
por: Schommer, Nina N., et al.
Publicado: (2019)

The HIV-1 Vpr and glucocorticoid receptor complex is a gain of function interaction that prevents the nuclear localization of PARP-1
por: Muthumani, Karuppiah, et al.
Publicado: (2006)

Synthetic nucleic acid antibody prophylaxis confers rapid and durable protective immunity against Zika virus challenge
por: Choi, Hyeree, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_r9qf9kfb8c72bs6fr3v92571c9